Colistin (polymyxin E) is an important constituent of the polymyxin class of cationic polypeptide antibiotics. Intrarenal oxidative stress can contribute to colistin-induced nephrotoxicity. Nicotinamide adenine dinucleotide 3-phosphate oxidases (Noxs) are important sources of reactive oxygen species. Among the various types of Noxs, Nox4 is predominantly expressed in the kidney.
Introduction
The increasing prevalence of infections caused by MDR Gramnegative bacteria represents a global medical challenge. Colistin (polymyxin E) is an important constituent of the polymyxin class of cationic polypeptide antibiotics. Its use was mostly superseded in the 1970s because of potential toxicity, notably nephrotoxicity. 1, 2 In the past decade, interest in colistin has been revived and it is now being used more frequently as a last-line therapy for infections caused by MDR Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. [1] [2] [3] Colistin is administered parenterally as sodium colistin methane sulfonate (CMS), an inactive prodrug. CMS is then converted in vivo to colistin, the active antibacterial, which is more toxic than CMS. 4, 5 The administration of CMS has been associated with nephrotoxicity in experimental animals and humans. Rates of nephrotoxicity in patients receiving the currently recommended CMS dosage regimens are often 45%-55%. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Although the mechanism underlying colistininduced nephrotoxicity remains unknown, it appears to be related to the total dose of CMS and duration of therapy. Moreover, it is usually reversible upon cessation of therapy. 4 Apart from reversibility, nephrotoxicity is currently a major dose-limiting adverse effect that impacts the clinical use of CMS. Recent studies suggest that oxidative stress is a central factor that drives colistin-induced nephrotoxicity. Notably, oxidative stress has been suggested to play a key role in nephrotoxicity caused by other drugs, including gentamicin, vancomycin and cisplatin. [14] [15] [16] Various sources of reactive oxygen species (ROS) have been identified, including xanthine oxidase, NADPH oxidase (Nox) and mitochondrial enzymes. The Nox family is composed of seven members (Nox1-5, DUOX1 and DUOX2). Among these, Nox4 is highly expressed in the kidney and has been implicated in the production of ROS in kidneys in both basal and pathological conditions, such as diabetic nephrotoxicity and chronic kidney disease. The upregulation of Nox4 may be important in renal oxidative stress and kidney injury. 18, 19 Although growing evidence indicates involvement of Nox4 in renal pathology, a paucity of information is available about the role of Nox4 in acute kidney injury (AKI).
We investigated the role of Nox4 and benefit of Nox4 inhibition in colistin-induced AKI using in vivo and in vitro models.
Materials and methods

Reagents
Colistin sulphate and CMS were purchased from Sigma-Aldrich (St Louis, MO, USA). GKT137831, a selective inhibitor of Nox1/4 {2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo [4, 3-c] pyridine-3, 6(2H, 5H)-dione} (GKT137831) was generously provided by Genkyotex (Chemin des Aulx, Plan-les-Ouates, Switzerland). SB431542 was purchased from R&D Systems (Minneapolis, MN, USA).
Cell culture
HK-2 cells (human renal proximal tubular epithelial cell line) were obtained from the Korean cell line bank (KCLB V R , Seoul, South Korea). HK-2 cells were cultured in RPMI-1640 supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were incubated at 37 C under 5% CO 2 in a humidified incubator. Subconfluent cells were starved for 12 h in RPMI without FBS and then incubated with either control medium (serum-free RPMI) or various concentrations of the colistin agents diluted in serum-free medium for the indicated time periods.
Plasmid and transfection
HK-2 cells were transiently transfected using Lipofectamine 3000 or RNAiMAX (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. Nox4 cDNA was subcloned into a pcDNA3 vector; the empty pcDNA3 vector was used as a negative control. Nox4 cDNA and pcDNA3 vector were kindly provided by the Bae laboratory (Ehwa Womans University, Korea). siRNAs targeting Nox4 were purchased from Dharmacon (Lafayette, CO, USA). Control scrambled siRNA was purchased from Invitrogen.
Immunoblotting
The lysates were resolved by SDS-PAGE. Polyvinylidene difluoride (PVDF) membranes with proteins were blocked and incubated for 2 h at room temperature, as described previously. 20 Further details of this method are available as Supplementary data at JAC Online. Antibody for Nox4 was from Abcam (Cambridge, MA, USA). Antibodies for pp38 and p-JNK (where JNK stands for c-Jun N-terminal kinase) were obtained from Cell Signaling Technology (Denver, MA, USA). Anti-p38, JNK, p-ERK (where ERK stands for extracellular signal-regulated kinase), ERK and b-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell viability
Cell viability was assessed using the MTT assay as described previously. 20 Further details of this method are available as Supplementary data.
Caspase 3/7 activity assay
Cells seeded in 96-well plates were incubated with the Caspase-Glo 3/7 substrate reagent (Promega, Madison, WI, USA) at 37 C for 30 min. The samples were transferred to a white-walled plate and the luminescence signal was measured using a Lumat LB953 luminometer (EG&G Berthhold, Bad Wildbad, Germany).
Quantification of TGF-b level
The TGF-b ELISA kit was purchased from Invitrogen (San Diego, CA, USA). The amounts of TGF-b at 10 min, 20 min, 30 min, 1 h, 2 h, 12 h and 24 h after colistin exposure were measured according to the manufacturer's protocol. After finishing the sampling steps, the optical density of each well was measured at 450 nm with the correction wavelength set at 540 nm.
Quantitative real-time PCR
Briefly, total cellular RNA was isolated using Trizol (Invitrogen, Carlsbad, CA, USA) and 1 lg of RNA was reverse transcribed using oligo(dT) and M-MLV reverse transcriptase (Promega) according to the manufacturer's protocol, as described previously. 21 Assay used the following primer sets: NOX-4, 5 0 -GGC TGG AGG CAT TGG AGT AA-3 0 (forward) and 5 0 -CCA GTC ATC CAA CAG GGT GTT-3 0 (reverse); and b-actin, 5 0 -TCAAGATCATTGCTCCTCCTG-3 0 (forward) and 5 0 -CTGCTTGCTGATCCACATCTG-3 0 (reverse). The b-actin gene was used as a control for calculation of DCt. The RT-PCR data were analysed using the 2 #(DDCt) method. 
Amplex red assay
Intercellular ROS detection
The oxidative fluorescent dye dihydroethidium (DHE) was obtained from Thermo Fisher Scientific Inc. Cells were incubated on glass slides in 12-well plates. After fixation with cold methanol for 10 min and permeabilization for 30 min with 1% BSA, cellular immunofluorescence was evaluated by staining with DHE for 40 min. The nuclei were counterstained with DAPI (Molecular Probes, Carlsbad, CA, USA) and the cells were then washed with ice-cold PBS three times for 5 min and examined by confocal microscopy (LSM710; Carl Zeiss, Jena, Germany). Representative images are shown from at least three independent experiments with similar results.
Animal models
Thirty-two Sprague-Dawley rats, 8 weeks old and weighing 200-250 g, were used. The rats were kept in cages in a 12 h light/12 h dark cycle at 22+2 C and were provided with food and water ad libitum. The institutional Animal Care and Use Committee of Konyang University approved the animal care protocol for the experiments performed in the study. Experimental animals were cared for and used in accordance with National Institute of Health guidelines.
Experimental design
Animals were randomly divided into four groups. Following a 5 day adaptation period, the 32 rats were divided into a control group [group 1 Role of Nox4 in colistin-induced kidney injury JAC (G1)], GTK137831 [10 mg/kg/day, group 2 (G2)], a group given colistin [300000 IU/kg/day, group 3 (G3)] and a group given colistin (300000 IU/kg/day) plus GKT137831 [group 4 (G4)], and placed into separate cages. G2 and G4 were given 300000 IU/kg colistin per day for 6 days intraperitoneally. G2 and G4 were given 10 mg/kg GKT137831 by gavage daily for 6 days. At day 7 the rats were exsanguinated and blood and tissues were obtained. Further details of this method are available as Supplementary data at JAC Online and the scheme for the animal study is shown in Figure S1 (also available as Supplementary data at JAC Online).
Biochemical marker determination in blood samples
An automatic biochemical analyser (Hitachi 7600, Ichige, Japan) was employed to determine blood urea nitrogen and serum creatinine. The novel marker of early-stage kidney injury, serum neutrophil gelatinase-associated lipocalin (sNGAL), was measured using ELISA kits (R&D Systems).
Histological examinations
The fixed left kidney was dehydrated in ethanol and embedded in paraffin. Kidney tissue blocks were cut into 3 lm sections and subjected to haematoxylin-eosin staining and periodic acid-Schiff staining.
Immunohistochemistry
The paraffin samples were cut at 2 lm thickness, de-paraffinized and rehydrated. After removing endogenous peroxidase with 3% H 2 O 2 , slides were pre-incubated with 10% fetal calf serum in Dako buffer (Dako) to block nonspecific reaction. The samples were incubated with goat polyclonal antibody against 8-hydroxyguanosine (8-OHdG) (2 lg/mL, Abcam, San Francisco, CA, USA, ab10802) overnight at 4 C. Secondary antibodies were applied for 1 h at room temperature in 10% FCS/Dako buffer. Finally, the sections were incubated with avidin peroxidase (1:100; Sigma-Aldrich) in 10% FCS/Dako buffer for 1 h at room temperature. Antibody binding was routinely visualized using diaminobenzidine (Sigma-Aldrich). The sections were counterstained with haematoxylin, dehydrated and mounted in Eukitt.
Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay
The TUNEL assay was conducted by using a TUNEL detection kit according to the manufacturer's instructions (Apotag, HRP kit DBA, Milan, Italy). Further details of this method are available as Supplementary data.
Statistical analyses
Statistical test were performed using R (version 2.15.0, R Development Core Team). Data are shown as means + SD. Differences between two groups were assessed using Student's t-test. Differences among three or more groups were evaluated by analysis of variance followed by Bonferroni multiple comparison tests.
Results
Effects of colistin on cell viability
We explored the use of the HK-2 immortalized human proximal tubule epithelial cell line as an in vitro model of colistin-induced renal damage. To determine the effect of colistin on cell survival, the MTT assay was used. HK-2 cells were treated with colistin (50 lg/mL). Cell survival was reduced in a time-dependent manner for 48 h ( Figure 1 ). As 50% of cells survived after treatment with 50 lg/mL for 24 h, this dose was chosen for further assays.
Colistin induces Nox4 expression
We first examined the effects of colistin (50 lg/mL) on Nox4 protein and mRNA transcript levels in cultured HK-2 cells. After colistin exposure, there was a significant increase in NOX4 expression within 10 min (Figure 2a ). NOX4 mRNA transcript levels peaked 30 min after colistin exposure and then decreased; however, these levels remained higher than those in control (untreated) cells for 24 h. Colistin also increased Nox4 protein levels as after colistin exposure there was a gradual increase in Nox4 protein expression levels for 24 h (Figure 2b) .
A role for Nox4 in colistin-induced apoptosis in HK-2 cells
To examine whether Nox4 was involved in colistin-induced HK-2 cell apoptosis, we infected HK-2 cells with NOX4-targeting or control small interfering RNA (siRNA). After incubating HK-2 cells with colistin for 24 h, caspase 3/7 activity was assessed. NOX4 knockdown by siRNA led to significantly reduced caspase 3/7 activity at 1, 2, 12 and 24 h after colistin exposure (Figure 3a) . Pretreatment of HK-2 cells with the specific Nox1/4 inhibitor GKT137831 (20 lg/mL) also ameliorated the apoptotic response induced by colistin, as indicated by levels of caspase 3/7 activation (Figure 3b) . Moreover, silencing of NOX4 also improved the survival of HK-2 cells in response to colistin, as measured using the ATPlite assay (Figure 3c ). Pretreatment with GKT137831 phenocopied the renoprotective effects observed with NOX4 knockdown (Figure 3d ).
TGF-b induces Nox4 expression in HK-2 cells
To explore whether HK-2 cells exposed to hypoxia secrete TGF-b1, the TGF-b1 levels in colistin-exposed HK-2 cells were assessed by ELISA. Levels of TGF-b increased within 5 min and peaked at 1 h after colistin exposure to HK-2 cells. TGF-b levels decreased sharply Jeong et al.
after 1 h and remained low for 24 h (Figure 4a ). These findings suggest that colistin may increase Nox4-mediated HK-2 cell apoptosis through endogenous production of TGF-b1. To investigate the functional relevance of TGF-b1 produced by colistin-exposed HK-2 cells, HK-2 cells were incubated with and without the TGF-b1 type I tyrosine kinase inhibitor SB431542. Blockade of TGF-b signalling with SB431542 significantly reduced colistin-induced Nox4 protein and mRNA transcript levels (Figure 4b and c) .
Effect of Nox4 inhibition on colistin-induced cellular ROS levels
We measured superoxide generation after colistin exposure in HK-2 cells with and without NOX4 knockdown or treated with GKT137831 or not using DHE staining (Figure 5a and b). We also measured H 2 O 2 generation using Amplex red assays in cells treated with GKT137831 or not after colistin exposure (Figure 5c ). The presence of colistin caused a significant increase in ROS production 1 and 2 h after colistin exposure. Intriguingly, the extent of colistin-induced ROS levels could be significantly suppressed by either NOX4 knockdown or GKT137831 pretreatment.
Mitogen-activated protein kinase (MAPK) pathways mediate redox-sensitive, colistin-induced apoptosis in HK-2 cells
To delineate the signalling mechanisms underlying colistin-and Nox4-mediated apoptosis, we analysed activation of the redoxsensitive MAPK pathways p38, JNK and ERK. Colistin (50 lg/mL) treatment led to increased phosphorylation of p38, JNK and ERK after 2 h. Levels of Bax also increased (Figure 6a and b) .
To determine whether MAPK activation was redox and Nox4 dependent, we knocked down NOX4 expression using siRNA. NOX4 knockdown significantly reduced colistin-induced phosphorylation of p38, JNK and ERK. Levels of Bax also decreased (Figure 6a) . The pharmacological inhibition of Nox4 with GKT137831 phenocopied these findings (Figure 6b) .
Effect of Nox4 inhibition on colistin-dependent effects on renal function
In a rat model of colistin-induced acute renal injury, serum was collected and tested for biochemical parameters. Compared with G1, blood urea nitrogen and plasma creatinine showed no changes in any of the experimental groups (G2, G3 and G4) (in G1, G2, G3 and G4, respectively: blood urea nitrogen 13.41+1.4, 13.05+3.1, 14.2+2.8 and 13.7+1.4 mg/dL; creatinine 0.18+0.04, 0.23+0.05, 0.21+0.06 and 0.21+0.03 mg/dL). Serum levels of sNGAL were significantly elevated in G3 (2.77+0.11 ng/mL) compared with G1 (1.20+0.19 ng/mL) (P , 0.01). The levels of sNGAL were not significantly different between G1 and G4 (2.38+0.14 ng/mL) (P . 0.05) ( Table S1 ).
Effect of Nox4 inhibition on colistin-induced changes in renal morphology
Histological analysis of kidney tissues from rats treated with sterile saline revealed normal renal cortex and glomeruli. However, kidneys from rats treated with CMS (300000 IU/kg/day) showed slight focal tubular dilatations, epithelial cell vacuolar degeneration, brush border blurring and tubular epithelial cell shedding. However, administering GKT137831 ameliorated kidney injury in CMS-treated rats ( Figure S2a-h) .
Effects of Nox4 inhibition on colistin-induced renal ROS production and renal tubular apoptosis
We evaluated oxidative stress in renal tissues of CMS-treated rats by immunostaining for 8-OHdG (Figure 7a and b) . The intensity of 8-OHdG staining in kidney tissues from CMS-treated rats was stronger in renal tubules compared with tissues from control rats. Administration of GKT137831 to CMS-treated rats restored the intensity of 8-OHdG staining to the level observed in controls. TUNEL immunostaining was performed to evaluate renal tubular cell apoptosis. Kidneys from the CMS group showed a significant increase in TUNEL-positive tubular epithelial cells (Figure 7c and d) . Meanwhile, fewer TUNEL-positive cells were observed in the CMS ! GKT137831-treated rats compared with the CMS-treated group (P , 0.001). Role of Nox4 in colistin-induced kidney injury
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Discussion
AKI associated with nephrotoxic drug use is among the most serious complications experienced by hospitalized patients. Indeed, AKI can be life threatening and preventative measures, such as hydration and the use of antioxidants to preserve renal functions, have little clinical efficacy. Therefore, a new prevention strategy aimed at attenuating drug-induced AKI would be highly desirable.
Previous studies have shown that Nox4 expression in the kidney is associated with the development and progression of chronic kidney disease, particularly diabetic nephrotoxicity with renal fibrosis. 19, 22, 23 However, the role of Nox4 in AKI is not well characterized. In our present study, to our knowledge, we showed for the first time that Nox4 expression was significantly increased after colistin exposure using real-time PCR and western blotting. Exposure of HK-2 cells to colistin caused significant cell death and apoptosis, which could be overcome by Nox4 inhibition. Moreover, Role of Nox4 in colistin-induced kidney injury JAC administering GKT137831 to CMS-treated rats mitigated tubular cell injury and decreased apoptosis in this animal model of colistin-induced nephrotoxicity.
Although the exact mechanisms whereby colistin causes AKI remain unclear, the available experimental evidence suggests that oxidative stress and tubular apoptosis each contribute to AKI. Several studies have shown that colistin directly induces caspasedependent apoptosis in cultured renal tubular cells. 24, 25 In this present study, colistin was found to activate caspase 3/7 activity, and NOX4 knockdown with siRNA or Nox4 inhibition with GKT137831 directly attenuated colistin-induced activation of caspase 3/7 in renal proximal tubular cells. Consistent with these findings, we found that the Bax-to-Bcl-2 ratio was significantly decreased after Nox4 inhibition. Furthermore, these changes resulted in fewer TUNEL-positive apoptotic cells in an animal model of colistin-induced nephrotoxicity.
The pathogenesis of colistin-induced apoptosis is not clear; however, ROS are thought to mediate toxic renal injury in colistininduced nephrotoxicity. [14] [15] [16] 24, 26 Several studies have shown either directly or indirectly that colistin administration augments ROS production and renal oxidative stress mediates cell membrane damage and leads to cellular apoptosis. 24, 27 Several previous studies also reported that administration of N-acetylcysteine, ascorbic acid and melatonin prevented colistin-induced nephrotoxicity in a colistin-induced AKI rat model. 15, 17, 26 However, the renoprotective effects of these compounds remain controversial. 28 Our present data suggest that the use of an antioxidant for free radical scavenging may not be an ideal compound for preventing colistin-induced AKI. Nox4 is an important source of ROS in the kidney. Accordingly, the direct inhibition of ROS sources by inhibiting Nox4 could markedly attenuate colistin-induced renal and plasma oxidative stress, as indicated by increased renal superoxide production and accumulation of 8-OHdG, along with our findings related to plasma superoxide dismutase activities in vivo, the Amplex red assay and DHE staining in vitro. Together, these data indicate that Nox4 is an important source of ROS in colistininduced nephrotoxicity.
ROS can trigger apoptosis via multiple mechanisms. Among these mechanisms, MAPK pathways are well documented redoxsensitive mediators involved in the modulation of apoptosis. 16, 24, [29] [30] [31] [32] Previous studies have demonstrated that in response to increased ROS production, the activation of p38 and JNK directly affects the phosphorylation and activation of pro-apoptotic bcl-2 family proteins, such as Bim and Bax. 33, 34 Administration of gentamicin and vancomycin acts as a stimulus to trigger MAPK cascades, especially p38, which can promote kidney injury. [35] [36] [37] Dai et al. 16 reported a similar pro-apoptotic role of p38 and pJNK in colistin-induced apoptosis. In this present study, we found that the p38, JNK and ERK MAPK pathways were critical in mediating colistin-induced HK-2 cell apoptosis. Persistent activation of the p38 and JNK signalling pathways can mediate cellular apoptosis, whereas the ERK signalling pathway activation typically drives cellular proliferation, migration and invasion. 38 Interestingly, ERK activity was also increased after colistin exposure and decreased upon Nox4 inhibition, similar to the p38 and JNK MAPKs. Conflicting data have been published about the role of ERK in kidney injury. In instances of drug-induced nephrotoxicity, such as cisplatinassociated nephrotoxicity, stimulation of ERK occurs via epidermal growth factor receptor (EGF-R)/Src signalling and mediates DNA damage-induced apoptosis. 39 How ROS activates MAPKs in HK-2 cells is unclear. In other cells, evidence suggests that NADPH oxidase-mediated MAPK activation requires apoptosis signal regulating inase-1, a redox-sensitive member of the MAPK kinase kinase (MAPKKK) family. 33, 34 However, whether this kinase has a role in mediating colistin-induced HK-2 cell apoptosis remains to be confirmed. Transforming growth factor (TGF)-b is a growth factor that affects many cellular processes involved in injury and repair, although its role in AKI remains unclear. The complexity of TGF-b signalling may account for its pleiotropic effects, which vary depending on the target cell type and microenvironment. 34, 40 TGFb signalling has been shown in vitro to alter many cellular processes that may be either beneficial or detrimental to the tubular response in AKI. TGF-b stimulates epithelial de-differentiation, so it may Representative photomicrographs of immunostaining for renal 8-OHdG 7 days after intraperitoneal injection of colistin. The colistin-treated rats were administered GKT137831 or not (a). Image analysis of the amount and intensity of staining (b). Representative photomicrographs of TUNEL-stained sections of kidneys harvested 7 days after intraperitoneal injection of colistin in rats administered GKT137831 or not; control rats, rats treated with GKT137831, rats treated with colistin and normal saline, and rats treated with colistin and GKT137831 (c). Image analysis of the amount and intensity of staining. The number of TUNEL-positive renal tubular cells was increased in rats with colistin-induced nephrotoxicity and was markedly decreased by administration of GKT137831 (d). Data represent means + SD; n " 4-5. **P , 0.01 and ***P , 0.001 versus control and #P , 0.05 and ###P , 0.001 versus colistin alone. Magnification, %200; scale bar, 100 lm. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Role of Nox4 in colistin-induced kidney injury JAC facilitate proximal tubule repair by accelerating the dedifferentiation of surviving epithelial cells, which is an important initial step in renal tissue repair. 39 However, TGF-b can also increase apoptosis in proximal tubule cells, which could play an important pathological role in ischaemic, septic and toxin-induced forms of AKI. [41] [42] [43] [44] [45] [46] The findings reported herein show, for the first time to our knowledge, that TGF-b markedly increased prior to the elevation of Nox4 levels under conditions of colistin-induced AKI. We confirmed our findings using a specific inhibitor of TGF-b receptor kinase, SB431542, which reduced the expression of Nox4 and rescued colistin-induced apoptosis. Together, these findings strongly support a model in which TGF-b-induced Nox4 expression acts as an important signalling effector to mediate colistin-induced AKI.
There were some limitations in this study. First, it appeared that the sample size of eight mice may not be sufficient to detect a difference in biochemical markers. Second, 40 mg/kg of GKT137831 was administered for 6 days with colistin injection. However, few reports have investigated the prevention of AKI by GTK137831; therefore, it is not clear whether the dosage and duration used in this study were adequate for renoprotection in colistin-induced nephrotoxicity.
In summary, our current results indicate that the inhibition of Nox4 might provide a unique way to prevent colistin-associated AKI. To the best of our knowledge, our present study is the first to suggest that nephrotoxicity driven by colistin-induced oxidative stress involves the TGF-b-mediated induction of Nox4 to then drive redox signalling (Figure 8 ). Our data also strongly suggest that the renoprotective effects of inhibiting Nox4 involve Nox4-dependent reductions in oxidative damage and apoptosis. Along with colistin, other antibiotics and chemotherapeutic agents can cause AKI by inducing ROS production in mammalian cells, which leads to DNA, protein and lipid damage. 47 Thus, apart from colistin, further study is needed to determine whether the renoprotective effects of Nox4 inhibition can extend its protective role in other toxinassociated types of AKI.
In conclusion, based on the findings obtained from our current in vitro and in vivo experiments, we propose that colistin upregulates the expression of Nox4 via TGF-b activation and causes increased ROS production. The enhanced ROS production triggers induction of the MAPK pathways. The siRNAmediated knockdown of NOX4 expression and pharmacological inhibition of Nox4 activity further support a model whereby colistin induces renal cellular toxicity that is dependent upon Nox4 activation. Thus, inhibition of Nox4 could be a new protective therapeutic strategy that targets toxin-induced nephrotoxicity.
